Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Authors:
Open Access
- 29 April 2014
- journal article
- video audio-media
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 86,p. e51485
Abstract
One of the key challenges to improved testing of new experimental therapeutics in renal cell carcinoma (RCC) is the development of models that faithfully recapitulate early- and late-stage metastatic disease progression. Typical tumor implantation models utilize ectopic or orthotopic primary tumor implantation, but few include systemic spontaneous metastatic disease that mimics the clinical setting. This protocol describes the key steps to develop RCC disease progression stages similar to patients. First, it uses a highly metastatic mouse tumor cell line in a syngeneic model to show orthotopic tumor cell implantation. Methods include superficial and internal implantation into the sub-capsular space with cells combined with matrigel to prevent leakage and early spread. Next it describes the procedures for excision of tumor-bearing kidney (nephrectomy), with critical pre- and post- surgical mouse care. Finally, it outlines the steps necessary to monitor and assess micro-and macro-metastatic disease progression, including bioluminescent imaging as well provides a detailed visual necropsy guide to score systemic disease distribution. The goal of this protocol description is to facilitate the widespread use of clinically relevant metastatic RCC models to improve the predictive value of future therapeutic testing.Keywords
This publication has 15 references indexed in Scilit:
- Renal cell carcinoma: translational aspects of metabolism and therapeutic consequencesKidney International, 2013
- A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic DrugsCancer Research, 2013
- Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinomaBiomedicine & Pharmacotherapy, 2012
- Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of originInternational Journal of Cancer, 2011
- Mouse models of advanced spontaneous metastasis for experimental therapeuticsNature Reviews Cancer, 2011
- An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune ResponsesJournal of Visualized Experiments, 2010
- Combination Therapy of Interleukin-2 and Sorafenib Improves Survival Benefits and Prevents Spontaneous Pulmonary Metastasis in Murine Renal Cell Carcinoma ModelsJapanese Journal of Clinical Oncology, 2010
- Preclinical Drug Development Must Consider the Impact on MetastasisClinical Cancer Research, 2009
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor AngiogenesisCancer Cell, 2009
- Characterization of the invasive and metastatic phenotype in human renal cell carcinomaClinical & Experimental Metastasis, 1991